Hamilton Point Investment Advisors’s SPDR Gold Trust GLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Sell
1,999
-68
-3% -$28.2K 0.1% 90
2026
Q1
$889K Hold
2,067
0.14% 80
2025
Q4
$819K Sell
2,067
-779
-27% -$298K 0.12% 82
2025
Q3
$1.01M Buy
2,846
+122
+4% +$38.9K 0.16% 72
2025
Q2
$830K Buy
2,724
+8
+0.3% +$2.42K 0.14% 80
2025
Q1
$783K Buy
2,716
+587
+28% +$155K 0.14% 81
2024
Q4
$515K Buy
2,129
+170
+9% +$41.8K 0.09% 90
2024
Q3
$476K Hold
1,959
0.08% 91
2024
Q2
$421K Hold
1,959
0.08% 91
2024
Q1
$403K Sell
1,959
-133
-6% -$25.5K 0.08% 91
2023
Q4
$400K Buy
2,092
+9
+0.4% +$1.65K 0.08% 98
2023
Q3
$357K Sell
2,083
-5
-0.2% -$894 0.09% 93
2023
Q2
$372K Sell
2,088
-5,540
-73% -$1.02M 0.09% 94
2023
Q1
$1.4M Buy
+7,628
New +$1.34M 0.34% 59

Other funds holding GLD

Hamilton Point Investment Advisors's GLD Position: Q2 2026 in Review

Hamilton Point Investment Advisors reduced its SPDR Gold Trust (GLD) stake by 3.3% in Q2 2026, selling an estimated $28.2K and leaving 1,999 shares worth $736K. The position accounts for 0.1% of the portfolio, ranked #90.

Hamilton Point Investment Advisors first reported a position in GLD in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.4M in Q1 2023. 1,308 funds tracked by Wall St. Rank hold GLD as of Q2 2026.

  • Hamilton Point Investment Advisors held 1,999 shares of SPDR Gold Trust worth $736K as of Q2 2026.
  • Hamilton Point Investment Advisors sold 68 SPDR Gold Trust shares in Q2 2026, an estimated $28.2K.
  • SPDR Gold Trust made up 0.1% of Hamilton Point Investment Advisors's portfolio in Q2 2026, its #90 holding.
  • Hamilton Point Investment Advisors first reported a position in SPDR Gold Trust in Q1 2023 and has held it in 14 quarters since.
  • Hamilton Point Investment Advisors's SPDR Gold Trust position peaked at $1.4M in Q1 2023.
  • 1,308 funds tracked by Wall St. Rank held SPDR Gold Trust as of Q2 2026.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.